Investment Type: Venture Capital
Mentions in press and media 5
Date | Title | Description | Source |
08.02.2012 | Cancer vaccine developer appoints life sciences entrepreneur | Last month, Berwyn, Pennsylvania-based Formula Pharmaceuticals added pharmaceutical veteran Martyn G... | medcitynew... |
15.04.2009 | Cancer drug maker BiPar sells to Sanofi-aventis for $500M | BiPar Sciences, maker of tumor-targeting cancer treatments, will be acquired by public global pharma... | venturebea... |
13.01.2009 | BiPar snags $20M for inhibitor-based cancer therapies | Pharmaceutical firm BiPar Sciences just brought in $20 million in private equity and venture debt to... | venturebea... |
28.01.2003 | PolyTechnos leads EUR 10 million second round funding for GI... | PolyTechnos leads EUR 10 million second round funding for GIGA STREAM UMTS Technologies Gm... 28-01... | cambridgen... |
- | Cancer vaccine developer appoints life sciences entrepreneur | A cancer vaccine developer has appointed a life sciences entrepreneur as chairman. Dr. Wolfgang Ost... | medcitynew... |